Trials / Terminated
TerminatedNCT00928772
Cranial Electro Therapy Stimulation in Reducing Perioperative Anxiety
The Effect of Cranial Electro Therapy Stimulation in Reducing Perioperative Anxiety for Patients Undergoing First Eye Cataract Surgery
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 115 (actual)
- Sponsor
- University of Oklahoma · Academic / Other
- Sex
- All
- Age
- 50 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
Cranial electro stimulation (CES) provides safe, adequate, side-effect free sedation without excessive drowsiness in preoperative settings.
Detailed description
CES Alpha-Stim is a non-invasive device which has been in place and has been approved for patients to reduce anxiety by the FDA. This study involves the use of CES Alpha-Stim device applied to the patient 30 minutes before and through-out cataract surgery procedure and then to measure the level of anxiety and discomfort by using a visual analog scale (VAS). We propose that by applying the device the patients will be able to have markedly less level of anxiety and discomfort before and during the surgery and will ultimately avoid the traditional use of sedative or analgesic drugs being used for these kinds of surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CRANIAL ELECTROTHERAPY (Alpha Stim) + SHAM MIDAZOLAM | APPLYING OF ELECTRODES ON THE EAR LOBES AND TEMPLES WHICH ARE SENDING AN ACTIVE MICROCURRENT THROUGH THE MIDBRAIN PRODUCING SEDATION WITHOUT PHARMACOLOGICAL AGENTS AND GIVING NORMAL SALINE AS A SHAM DRUG SEDATION |
| DRUG | MIDAZOLAM + SHAM ELECTRODES SIMULATING CRANIAL ELECTROTHERAPY | CONVENTIONAL METHOD OF PERIOPERATIVE SEDATION |
| OTHER | NO SEDATION WITH SHAM CRANIAL ELECTROSTIMULATION AND PLACEBO VERSED | NO ACTIVE SEDATION, ONLY SHAM ELECTRODES AND NORMAL SALINE SIMULATING MIDAZOLAM. |
Timeline
- Start date
- 2009-07-01
- Primary completion
- 2012-02-01
- Completion
- 2012-02-01
- First posted
- 2009-06-26
- Last updated
- 2017-04-20
- Results posted
- 2017-04-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00928772. Inclusion in this directory is not an endorsement.